Results 121 to 130 of about 246,923 (261)
Tolerability and Safety of Sublingual Immunotherapy in Patients with Tree Pollen Allergy in Daily Practice-An Open, Prospective, Non-Interventional Study. [PDF]
Owenier C +5 more
europepmc +1 more source
Pollen Allergy in a Changing Planetary Environment. [PDF]
Oh JW.
europepmc +1 more source
Pre‐Seasonal Treatment With Recombinant Carrier‐Based Birch Vaccine Improves Birch Pollen Allergy
We conducted a two stage SCIT trial with GNR‐127 containing a recombinant fusion protein consisting of Bet v 1 and Mal d 1‐derived peptides fused to PreS from HBV. Stage 1 identified two safe maximum tolerated doses (40 μg and 80 μg). In the following Stage 2, five preseasonal injections were well tolerated, induced dose‐dependent allergen‐specific IgG,
Musa R. Khaitov +43 more
wiley +1 more source
Using MASK‐air app data from 1042 users across 2690 weeks, this study compared the impact of regular versus as‐needed allergic rhinitis medication on symptom control and treatment satisfaction. Mixed‐effects linear regression models and sensitivity analyses revealed no significant differences between the two approaches, with results for oral ...
Bernardo Sousa‐Pinto +38 more
wiley +1 more source
Analysis of ceRNA Regulatory Mechanism of Rape Pollen Allergy Based on Whole-Transcriptome Sequencing of Peripheral Blood Mononuclear Cells. [PDF]
Wang Y +6 more
europepmc +1 more source
Mass spectrometry and pollen allergies [PDF]
Schenk, M.F. +3 more
openaire +2 more sources
BACKGROUND: Birch pollen-food allergy syndrome is triggered by cross-reactive allergens in plant-based foods. Environmental factors such as nitrogen fertilization may influence food allergenicity, but this has not been studied before.
R. Schrijvers +4 more
core +1 more source
Oral allergy syndrome to chicory associated with birch pollen allergy
BACKGROUND: A few cases of IgE-mediated chicory allergy with oral, cutaneous, and/or respiratory symptoms are reported. We present 4 patients with inhalant birch pollen allergy and oral allergy syndrome to chicory.
Ceuppens, J. L. +3 more
core +1 more source
Diagnostic performance of recombinant peanut allergens for anaphylaxis risk in children. (A) Study population and clinical group. (B) Component‐specific IgE cut‐offs and associated odds ratios. (C) Forest plot of odds ratios for anaphylaxis. (D) Clinical interpretation of component‐specific IgE cut‐offs. ABSTRACT Aim Component‐resolved diagnostics (CRD)
Lisa Gazzolari +10 more
wiley +1 more source
The influence of air pollution on pollen allergy sufferers. [PDF]
Berger M +4 more
europepmc +1 more source

